

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 6.29289755 |
| 2 | vocalization behavior (GO:0071625) | 5.66752188 |
| 3 | positive regulation of synapse maturation (GO:0090129) | 5.56718527 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.25413360 |
| 5 | protein localization to synapse (GO:0035418) | 4.78704957 |
| 6 | cerebellar granule cell differentiation (GO:0021707) | 4.73744325 |
| 7 | cell migration in hindbrain (GO:0021535) | 4.62332102 |
| 8 | neuron cell-cell adhesion (GO:0007158) | 4.54508258 |
| 9 | locomotory exploration behavior (GO:0035641) | 4.52482666 |
| 10 | neuronal ion channel clustering (GO:0045161) | 4.49149344 |
| 11 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.45629860 |
| 12 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.45629860 |
| 13 | glutamate secretion (GO:0014047) | 4.40023950 |
| 14 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.32403122 |
| 15 | synaptic vesicle maturation (GO:0016188) | 4.32365361 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.28482504 |
| 17 | regulation of synapse maturation (GO:0090128) | 4.25079984 |
| 18 | postsynaptic membrane organization (GO:0001941) | 4.24897267 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.22746402 |
| 20 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.15774819 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.14131364 |
| 22 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.02472939 |
| 23 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.98386122 |
| 24 | establishment of mitochondrion localization (GO:0051654) | 3.98366570 |
| 25 | cellular potassium ion homeostasis (GO:0030007) | 3.97941726 |
| 26 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.96381261 |
| 27 | dendritic spine organization (GO:0097061) | 3.90178684 |
| 28 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.89555271 |
| 29 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.88710041 |
| 30 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.86028902 |
| 31 | dendritic spine morphogenesis (GO:0060997) | 3.86008263 |
| 32 | sodium ion export (GO:0071436) | 3.84828846 |
| 33 | cell communication by electrical coupling (GO:0010644) | 3.83400797 |
| 34 | neuromuscular process controlling balance (GO:0050885) | 3.81253331 |
| 35 | positive regulation of dendritic spine development (GO:0060999) | 3.79461142 |
| 36 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.78687244 |
| 37 | regulation of synapse structural plasticity (GO:0051823) | 3.76961038 |
| 38 | exploration behavior (GO:0035640) | 3.72865001 |
| 39 | cellular sodium ion homeostasis (GO:0006883) | 3.71536201 |
| 40 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.70005649 |
| 41 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.66094424 |
| 42 | glutamate receptor signaling pathway (GO:0007215) | 3.65308864 |
| 43 | regulation of neurotransmitter secretion (GO:0046928) | 3.64353394 |
| 44 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.57861184 |
| 45 | mitochondrion transport along microtubule (GO:0047497) | 3.54484889 |
| 46 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.54484889 |
| 47 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.54376186 |
| 48 | neuromuscular synaptic transmission (GO:0007274) | 3.52957555 |
| 49 | regulation of synaptic vesicle transport (GO:1902803) | 3.52476256 |
| 50 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.52406103 |
| 51 | succinate metabolic process (GO:0006105) | 3.52276433 |
| 52 | neuronal action potential propagation (GO:0019227) | 3.51976418 |
| 53 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.48501666 |
| 54 | regulation of ARF protein signal transduction (GO:0032012) | 3.48121515 |
| 55 | synaptic transmission, glutamatergic (GO:0035249) | 3.46776830 |
| 56 | neuron-neuron synaptic transmission (GO:0007270) | 3.38975465 |
| 57 | startle response (GO:0001964) | 3.37890672 |
| 58 | gamma-aminobutyric acid transport (GO:0015812) | 3.37844284 |
| 59 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.36731124 |
| 60 | amino acid import (GO:0043090) | 3.35572199 |
| 61 | regulation of synaptic plasticity (GO:0048167) | 3.33780251 |
| 62 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.32539551 |
| 63 | chemosensory behavior (GO:0007635) | 3.32452853 |
| 64 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.31217798 |
| 65 | positive regulation of neurotransmitter transport (GO:0051590) | 3.30453781 |
| 66 | transferrin transport (GO:0033572) | 3.29211300 |
| 67 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.25689212 |
| 68 | activation of protein kinase A activity (GO:0034199) | 3.25454078 |
| 69 | proline transport (GO:0015824) | 3.25363779 |
| 70 | cell differentiation in hindbrain (GO:0021533) | 3.24422254 |
| 71 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.23259479 |
| 72 | long-term synaptic potentiation (GO:0060291) | 3.19390634 |
| 73 | detection of calcium ion (GO:0005513) | 3.18031058 |
| 74 | neurotransmitter transport (GO:0006836) | 3.17485212 |
| 75 | membrane repolarization (GO:0086009) | 3.16675560 |
| 76 | regulation of cofactor metabolic process (GO:0051193) | 3.16503761 |
| 77 | regulation of coenzyme metabolic process (GO:0051196) | 3.16503761 |
| 78 | calcium ion-dependent exocytosis (GO:0017156) | 3.15081597 |
| 79 | regulation of neurotransmitter transport (GO:0051588) | 3.13128939 |
| 80 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.12976226 |
| 81 | cerebellar Purkinje cell layer development (GO:0021680) | 3.12643350 |
| 82 | regulation of vesicle fusion (GO:0031338) | 3.12595002 |
| 83 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.10336879 |
| 84 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.08502885 |
| 85 | regulation of membrane repolarization (GO:0060306) | 3.08469548 |
| 86 | long-term memory (GO:0007616) | 3.08331674 |
| 87 | L-amino acid import (GO:0043092) | 3.08284496 |
| 88 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.07355893 |
| 89 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.05889401 |
| 90 | trivalent inorganic cation transport (GO:0072512) | 3.04405208 |
| 91 | ferric iron transport (GO:0015682) | 3.04405208 |
| 92 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.03227226 |
| 93 | ATP synthesis coupled proton transport (GO:0015986) | 3.03227226 |
| 94 | regulation of cell communication by electrical coupling (GO:0010649) | 3.03044179 |
| 95 | regulation of neurotransmitter levels (GO:0001505) | 3.02881852 |
| 96 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.01681640 |
| 97 | regulation of glutamate secretion (GO:0014048) | 2.99902104 |
| 98 | layer formation in cerebral cortex (GO:0021819) | 2.98551993 |
| 99 | behavioral fear response (GO:0001662) | 2.96874949 |
| 100 | behavioral defense response (GO:0002209) | 2.96874949 |
| 101 | neuromuscular process (GO:0050905) | 2.96840465 |
| 102 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.96171043 |
| 103 | regulation of ARF GTPase activity (GO:0032312) | 2.95539396 |
| 104 | axonal fasciculation (GO:0007413) | 2.95360719 |
| 105 | membrane depolarization (GO:0051899) | 2.94562826 |
| 106 | negative regulation of amino acid transport (GO:0051956) | 2.94224644 |
| 107 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.93742338 |
| 108 | regulation of dendrite morphogenesis (GO:0048814) | 2.93512569 |
| 109 | positive regulation of synapse assembly (GO:0051965) | 2.92127289 |
| 110 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.90779002 |
| 111 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.90766674 |
| 112 | behavioral response to cocaine (GO:0048148) | 2.90578924 |
| 113 | neuron recognition (GO:0008038) | 2.89027575 |
| 114 | membrane depolarization during action potential (GO:0086010) | 2.87390784 |
| 115 | learning (GO:0007612) | 2.85445036 |
| 116 | regulation of postsynaptic membrane potential (GO:0060078) | 2.84257717 |
| 117 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.83377787 |
| 118 | positive regulation of dendrite development (GO:1900006) | 2.83356629 |
| 119 | striatum development (GO:0021756) | 2.82252739 |
| 120 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.81626107 |
| 121 | axon ensheathment in central nervous system (GO:0032291) | 2.80880350 |
| 122 | central nervous system myelination (GO:0022010) | 2.80880350 |
| 123 | synaptic vesicle endocytosis (GO:0048488) | 2.80716584 |
| 124 | potassium ion homeostasis (GO:0055075) | 2.79658567 |
| 125 | positive regulation of membrane potential (GO:0045838) | 2.79532801 |
| 126 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.79131264 |
| 127 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.79079848 |
| 128 | neuromuscular process controlling posture (GO:0050884) | 2.78913020 |
| 129 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.78885952 |
| 130 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.78115985 |
| 131 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.77967047 |
| 132 | transmission of nerve impulse (GO:0019226) | 2.77587024 |
| 133 | tricarboxylic acid cycle (GO:0006099) | 2.77567696 |
| 134 | long term synaptic depression (GO:0060292) | 2.76151323 |
| 135 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.73097973 |
| 136 | synaptic vesicle transport (GO:0048489) | 2.71996926 |
| 137 | establishment of synaptic vesicle localization (GO:0097480) | 2.71996926 |
| 138 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.71563945 |
| 139 | fear response (GO:0042596) | 2.71539923 |
| 140 | regulation of synaptic transmission (GO:0050804) | 2.70438146 |
| 141 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.69959850 |
| 142 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.69959850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 8.43135436 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.23163557 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.22087145 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.98798560 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.91598553 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.87580295 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.80135204 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.77081151 |
| 9 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.74332941 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.74024867 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.66311254 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.65564581 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.63442811 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.57002893 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.57002893 |
| 16 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.53840348 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.52393580 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.52077261 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.43037726 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.39074695 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28228321 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.26908733 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.17116210 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16043503 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.08190596 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.05599204 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.98258096 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.94260147 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.88867559 |
| 30 | * P68_20966046_ChIP-Seq_HELA_Human | 1.87183500 |
| 31 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.85050673 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.84947966 |
| 33 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.72594504 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.71695426 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64462252 |
| 36 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.61093154 |
| 37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60414121 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57744031 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.50925585 |
| 40 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.49347646 |
| 41 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.48313082 |
| 42 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.46470888 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46351771 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45317783 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43307149 |
| 46 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.41271783 |
| 47 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.40208467 |
| 48 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.40018079 |
| 49 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.38682261 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36065992 |
| 51 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.34891323 |
| 52 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34539343 |
| 53 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.34385788 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33521276 |
| 55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.28938398 |
| 56 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.27380849 |
| 57 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27360141 |
| 58 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25073480 |
| 59 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.24442562 |
| 60 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.23389081 |
| 61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22363965 |
| 62 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.21761121 |
| 63 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21507111 |
| 64 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20276597 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20036406 |
| 66 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16487376 |
| 67 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15136936 |
| 68 | KDM2B_26808549_Chip-Seq_K562_Human | 1.14589170 |
| 69 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.14055358 |
| 70 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.13750506 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13209170 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13106913 |
| 73 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12848737 |
| 74 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12839996 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11699610 |
| 76 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.09742792 |
| 77 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09544716 |
| 78 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.08474919 |
| 79 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08448491 |
| 80 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07181795 |
| 81 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.06839843 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.06617392 |
| 83 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.06486301 |
| 84 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05961778 |
| 85 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.05463718 |
| 86 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04850291 |
| 87 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.02531262 |
| 88 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01974746 |
| 89 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01949458 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01146087 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01113616 |
| 92 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.99925489 |
| 93 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99460179 |
| 94 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99414274 |
| 95 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98489207 |
| 96 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98206213 |
| 97 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.97047402 |
| 98 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.96328007 |
| 99 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.96137547 |
| 100 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95281949 |
| 101 | AR_19668381_ChIP-Seq_PC3_Human | 0.95245844 |
| 102 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.94859293 |
| 103 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93868813 |
| 104 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.92504956 |
| 105 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.92254588 |
| 106 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90839471 |
| 107 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.90738527 |
| 108 | MYC_22102868_ChIP-Seq_BL_Human | 0.90480921 |
| 109 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.90462809 |
| 110 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.90432917 |
| 111 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90367913 |
| 112 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89684494 |
| 113 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89523346 |
| 114 | JUN_21703547_ChIP-Seq_K562_Human | 0.89429967 |
| 115 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.88634133 |
| 116 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88078464 |
| 117 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88007961 |
| 118 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88000270 |
| 119 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86919583 |
| 120 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86151551 |
| 121 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.85905952 |
| 122 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.85490480 |
| 123 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83956994 |
| 124 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81910459 |
| 125 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81825594 |
| 126 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.81774599 |
| 127 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.81406016 |
| 128 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.81099416 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.80198971 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79661452 |
| 131 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.73958880 |
| 132 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73479767 |
| 133 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.73440667 |
| 134 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.73075063 |
| 135 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.73075063 |
| 136 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.72619274 |
| 137 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.72054809 |
| 138 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.71462552 |
| 139 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.71248417 |
| 140 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70731822 |
| 141 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.70260478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.64933165 |
| 2 | MP0002822_catalepsy | 5.02267861 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.76045865 |
| 4 | MP0003880_abnormal_central_pattern | 3.71106994 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.52739125 |
| 6 | MP0009046_muscle_twitch | 3.10033629 |
| 7 | MP0009745_abnormal_behavioral_response | 3.07357158 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.97985687 |
| 9 | MP0000751_myopathy | 2.88152466 |
| 10 | MP0002064_seizures | 2.86320677 |
| 11 | MP0004270_analgesia | 2.47044220 |
| 12 | MP0002735_abnormal_chemical_nociception | 2.45857213 |
| 13 | MP0003646_muscle_fatigue | 2.43791395 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.29701190 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.23761749 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.02399054 |
| 17 | MP0004858_abnormal_nervous_system | 1.99174473 |
| 18 | MP0002272_abnormal_nervous_system | 1.98068734 |
| 19 | MP0003329_amyloid_beta_deposits | 1.97442026 |
| 20 | MP0002736_abnormal_nociception_after | 1.95497250 |
| 21 | MP0001440_abnormal_grooming_behavior | 1.94627359 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.92547529 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.85565883 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 1.84849774 |
| 25 | MP0004215_abnormal_myocardial_fiber | 1.75316514 |
| 26 | MP0008569_lethality_at_weaning | 1.71475302 |
| 27 | MP0003123_paternal_imprinting | 1.69966553 |
| 28 | MP0001970_abnormal_pain_threshold | 1.67943928 |
| 29 | MP0001486_abnormal_startle_reflex | 1.67343166 |
| 30 | MP0000749_muscle_degeneration | 1.65155072 |
| 31 | MP0004924_abnormal_behavior | 1.63932771 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.63932771 |
| 33 | MP0004233_abnormal_muscle_weight | 1.62245750 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.61207566 |
| 35 | MP0002067_abnormal_sensory_capabilities | 1.56186481 |
| 36 | MP0004142_abnormal_muscle_tone | 1.54262815 |
| 37 | MP0002184_abnormal_innervation | 1.53505993 |
| 38 | MP0001984_abnormal_olfaction | 1.49026880 |
| 39 | MP0002249_abnormal_larynx_morphology | 1.48344986 |
| 40 | MP0004036_abnormal_muscle_relaxation | 1.43461897 |
| 41 | MP0006276_abnormal_autonomic_nervous | 1.38888363 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.38143819 |
| 43 | MP0002557_abnormal_social/conspecific_i | 1.37716211 |
| 44 | MP0004484_altered_response_of | 1.36567634 |
| 45 | MP0000955_abnormal_spinal_cord | 1.35900049 |
| 46 | MP0002332_abnormal_exercise_endurance | 1.33283668 |
| 47 | MP0001529_abnormal_vocalization | 1.28901231 |
| 48 | MP0003075_altered_response_to | 1.27954098 |
| 49 | MP0003122_maternal_imprinting | 1.25929703 |
| 50 | MP0005171_absent_coat_pigmentation | 1.23161102 |
| 51 | MP0002066_abnormal_motor_capabilities/c | 1.23042070 |
| 52 | MP0005423_abnormal_somatic_nervous | 1.22074542 |
| 53 | MP0003137_abnormal_impulse_conducting | 1.21423851 |
| 54 | MP0005670_abnormal_white_adipose | 1.20139604 |
| 55 | MP0003879_abnormal_hair_cell | 1.19340931 |
| 56 | MP0002653_abnormal_ependyma_morphology | 1.18926375 |
| 57 | MP0004084_abnormal_cardiac_muscle | 1.17769068 |
| 58 | MP0000678_abnormal_parathyroid_gland | 1.17733858 |
| 59 | MP0001905_abnormal_dopamine_level | 1.16270747 |
| 60 | MP0003690_abnormal_glial_cell | 1.15104453 |
| 61 | MP0002882_abnormal_neuron_morphology | 1.14116480 |
| 62 | MP0004145_abnormal_muscle_electrophysio | 1.13972285 |
| 63 | MP0002269_muscular_atrophy | 1.11859519 |
| 64 | MP0004742_abnormal_vestibular_system | 1.10318231 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.09239401 |
| 66 | MP0003633_abnormal_nervous_system | 1.09183413 |
| 67 | MP0000778_abnormal_nervous_system | 1.09164018 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.08648270 |
| 69 | MP0004130_abnormal_muscle_cell | 1.06707352 |
| 70 | MP0005330_cardiomyopathy | 1.06198345 |
| 71 | MP0000747_muscle_weakness | 1.05302082 |
| 72 | MP0002106_abnormal_muscle_physiology | 1.03931810 |
| 73 | MP0004087_abnormal_muscle_fiber | 1.02123957 |
| 74 | MP0005409_darkened_coat_color | 1.01881350 |
| 75 | MP0002229_neurodegeneration | 1.01341359 |
| 76 | MP0004085_abnormal_heartbeat | 1.01074606 |
| 77 | MP0000750_abnormal_muscle_regeneration | 0.99716920 |
| 78 | MP0003861_abnormal_nervous_system | 0.99616291 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.99302541 |
| 80 | MP0005623_abnormal_meninges_morphology | 0.97599910 |
| 81 | MP0001963_abnormal_hearing_physiology | 0.97434626 |
| 82 | MP0005620_abnormal_muscle_contractility | 0.96312807 |
| 83 | MP0002972_abnormal_cardiac_muscle | 0.94900303 |
| 84 | MP0000759_abnormal_skeletal_muscle | 0.94531437 |
| 85 | MP0003632_abnormal_nervous_system | 0.91378436 |
| 86 | MP0004510_myositis | 0.91053460 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.90504724 |
| 88 | MP0003121_genomic_imprinting | 0.90423373 |
| 89 | MP0002090_abnormal_vision | 0.90148338 |
| 90 | MP0000920_abnormal_myelination | 0.89273894 |
| 91 | MP0005369_muscle_phenotype | 0.89113906 |
| 92 | MP0003631_nervous_system_phenotype | 0.87868522 |
| 93 | MP0008874_decreased_physiological_sensi | 0.87622912 |
| 94 | MP0002152_abnormal_brain_morphology | 0.87329312 |
| 95 | MP0002752_abnormal_somatic_nervous | 0.84900344 |
| 96 | MP0003698_abnormal_male_reproductive | 0.83051490 |
| 97 | MP0001188_hyperpigmentation | 0.82852487 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.80627412 |
| 99 | MP0005499_abnormal_olfactory_system | 0.80263192 |
| 100 | MP0005394_taste/olfaction_phenotype | 0.80263192 |
| 101 | MP0002089_abnormal_postnatal_growth/wei | 0.78598434 |
| 102 | MP0005646_abnormal_pituitary_gland | 0.78259022 |
| 103 | MP0000604_amyloidosis | 0.77221685 |
| 104 | MP0004885_abnormal_endolymph | 0.76253736 |
| 105 | MP0005535_abnormal_body_temperature | 0.75807766 |
| 106 | MP0001943_abnormal_respiration | 0.75539392 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.75217330 |
| 108 | MP0001177_atelectasis | 0.74212231 |
| 109 | MP0003385_abnormal_body_wall | 0.73277296 |
| 110 | MP0002069_abnormal_eating/drinking_beha | 0.72777511 |
| 111 | MP0000026_abnormal_inner_ear | 0.72472935 |
| 112 | MP0006035_abnormal_mitochondrial_morpho | 0.71638140 |
| 113 | MP0010769_abnormal_survival | 0.71496311 |
| 114 | MP0010770_preweaning_lethality | 0.69647172 |
| 115 | MP0002082_postnatal_lethality | 0.69647172 |
| 116 | MP0005385_cardiovascular_system_phenoty | 0.68992274 |
| 117 | MP0001544_abnormal_cardiovascular_syste | 0.68992274 |
| 118 | MP0003787_abnormal_imprinting | 0.68177810 |
| 119 | MP0010768_mortality/aging | 0.67828953 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.67736082 |
| 121 | MP0005410_abnormal_fertilization | 0.67395488 |
| 122 | MP0001299_abnormal_eye_distance/ | 0.67104579 |
| 123 | MP0005166_decreased_susceptibility_to | 0.66990410 |
| 124 | MP0003634_abnormal_glial_cell | 0.66848646 |
| 125 | MP0008260_abnormal_autophagy | 0.66066414 |
| 126 | MP0000681_abnormal_thyroid_gland | 0.61732887 |
| 127 | MP0002081_perinatal_lethality | 0.61507921 |
| 128 | MP0000534_abnormal_ureter_morphology | 0.61382506 |
| 129 | MP0002638_abnormal_pupillary_reflex | 0.61139602 |
| 130 | MP0003938_abnormal_ear_development | 0.61053801 |
| 131 | MP0006138_congestive_heart_failure | 0.60507958 |
| 132 | MP0001348_abnormal_lacrimal_gland | 0.59093935 |
| 133 | MP0003183_abnormal_peptide_metabolism | 0.58864398 |
| 134 | MP0002161_abnormal_fertility/fecundity | 0.58176773 |
| 135 | MP0003115_abnormal_respiratory_system | 0.58050008 |
| 136 | MP0008872_abnormal_physiological_respon | 0.56670564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.46680732 |
| 2 | Myokymia (HP:0002411) | 4.81175998 |
| 3 | Ankle clonus (HP:0011448) | 4.45078769 |
| 4 | Focal seizures (HP:0007359) | 4.40532305 |
| 5 | Visual hallucinations (HP:0002367) | 4.27715999 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.19679022 |
| 7 | Hyperventilation (HP:0002883) | 3.91946742 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 3.83229347 |
| 9 | Atonic seizures (HP:0010819) | 3.70656153 |
| 10 | Obstructive sleep apnea (HP:0002870) | 3.60303059 |
| 11 | Spastic gait (HP:0002064) | 3.60287730 |
| 12 | Exercise-induced myalgia (HP:0003738) | 3.58497313 |
| 13 | Dialeptic seizures (HP:0011146) | 3.51496693 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.37641055 |
| 15 | Febrile seizures (HP:0002373) | 3.32906713 |
| 16 | Absence seizures (HP:0002121) | 3.25012465 |
| 17 | Pheochromocytoma (HP:0002666) | 3.23514055 |
| 18 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.19569430 |
| 19 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.17150744 |
| 20 | Neurofibrillary tangles (HP:0002185) | 3.10155041 |
| 21 | Insomnia (HP:0100785) | 3.04786531 |
| 22 | Neuroendocrine neoplasm (HP:0100634) | 3.03799217 |
| 23 | Papilledema (HP:0001085) | 3.03441560 |
| 24 | Amblyopia (HP:0000646) | 2.93605107 |
| 25 | Generalized tonic-clonic seizures (HP:0002069) | 2.92959628 |
| 26 | Peripheral hypomyelination (HP:0007182) | 2.86208981 |
| 27 | Progressive macrocephaly (HP:0004481) | 2.84211237 |
| 28 | Acute encephalopathy (HP:0006846) | 2.83907780 |
| 29 | Hyperacusis (HP:0010780) | 2.77774793 |
| 30 | Sudden death (HP:0001699) | 2.76728186 |
| 31 | Exercise-induced muscle cramps (HP:0003710) | 2.76110021 |
| 32 | Cerebral inclusion bodies (HP:0100314) | 2.75517961 |
| 33 | Mitochondrial inheritance (HP:0001427) | 2.72678926 |
| 34 | Athetosis (HP:0002305) | 2.67829686 |
| 35 | Hand muscle atrophy (HP:0009130) | 2.66004367 |
| 36 | Impaired smooth pursuit (HP:0007772) | 2.65403079 |
| 37 | Dysdiadochokinesis (HP:0002075) | 2.63106256 |
| 38 | Dysmetric saccades (HP:0000641) | 2.62812843 |
| 39 | Genetic anticipation (HP:0003743) | 2.62260301 |
| 40 | Progressive inability to walk (HP:0002505) | 2.62028816 |
| 41 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.60899791 |
| 42 | Neuronal loss in central nervous system (HP:0002529) | 2.59180208 |
| 43 | Distal upper limb amyotrophy (HP:0007149) | 2.58420381 |
| 44 | Upper limb amyotrophy (HP:0009129) | 2.58420381 |
| 45 | Abnormality of the calf musculature (HP:0001430) | 2.50831499 |
| 46 | Stereotypic behavior (HP:0000733) | 2.49597463 |
| 47 | Pointed chin (HP:0000307) | 2.47543405 |
| 48 | Polyphagia (HP:0002591) | 2.45749554 |
| 49 | Abnormal eating behavior (HP:0100738) | 2.44111802 |
| 50 | Gaze-evoked nystagmus (HP:0000640) | 2.41698488 |
| 51 | Truncal ataxia (HP:0002078) | 2.41537906 |
| 52 | Decreased circulating renin level (HP:0003351) | 2.40374341 |
| 53 | Delusions (HP:0000746) | 2.39202533 |
| 54 | Increased variability in muscle fiber diameter (HP:0003557) | 2.37335558 |
| 55 | Supranuclear gaze palsy (HP:0000605) | 2.35646797 |
| 56 | Turricephaly (HP:0000262) | 2.35527914 |
| 57 | Increased CSF lactate (HP:0002490) | 2.33919596 |
| 58 | Urinary urgency (HP:0000012) | 2.32865396 |
| 59 | Cerebral hypomyelination (HP:0006808) | 2.32801693 |
| 60 | Sleep apnea (HP:0010535) | 2.30323611 |
| 61 | Primary atrial arrhythmia (HP:0001692) | 2.30126576 |
| 62 | Depression (HP:0000716) | 2.30108882 |
| 63 | Myotonia (HP:0002486) | 2.29600045 |
| 64 | Prolonged QT interval (HP:0001657) | 2.25475989 |
| 65 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.25212072 |
| 66 | Myoglobinuria (HP:0002913) | 2.24406164 |
| 67 | Limb dystonia (HP:0002451) | 2.24312015 |
| 68 | Calf muscle hypertrophy (HP:0008981) | 2.23586037 |
| 69 | Hypoventilation (HP:0002791) | 2.23255828 |
| 70 | Atrial fibrillation (HP:0005110) | 2.22577410 |
| 71 | Hepatocellular necrosis (HP:0001404) | 2.21567357 |
| 72 | Hypercortisolism (HP:0001578) | 2.21312196 |
| 73 | Impaired social interactions (HP:0000735) | 2.19587975 |
| 74 | Abnormal social behavior (HP:0012433) | 2.19587975 |
| 75 | Anxiety (HP:0000739) | 2.19341382 |
| 76 | Supraventricular tachycardia (HP:0004755) | 2.19279947 |
| 77 | Left ventricular hypertrophy (HP:0001712) | 2.19099958 |
| 78 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17443034 |
| 79 | Failure to thrive in infancy (HP:0001531) | 2.15769459 |
| 80 | Intention tremor (HP:0002080) | 2.15669010 |
| 81 | Supraventricular arrhythmia (HP:0005115) | 2.15545061 |
| 82 | Akinesia (HP:0002304) | 2.13767364 |
| 83 | Broad-based gait (HP:0002136) | 2.13516202 |
| 84 | Lower limb muscle weakness (HP:0007340) | 2.12832099 |
| 85 | Cerebral edema (HP:0002181) | 2.12216113 |
| 86 | Abnormality of the corticospinal tract (HP:0002492) | 2.11463392 |
| 87 | Poor eye contact (HP:0000817) | 2.11043792 |
| 88 | Abnormal EKG (HP:0003115) | 2.11039581 |
| 89 | Clonus (HP:0002169) | 2.10491854 |
| 90 | Impaired vibratory sensation (HP:0002495) | 2.10456841 |
| 91 | Apathy (HP:0000741) | 2.09702660 |
| 92 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.09274768 |
| 93 | Hypsarrhythmia (HP:0002521) | 2.08734622 |
| 94 | Syncope (HP:0001279) | 2.08692277 |
| 95 | Abnormality of binocular vision (HP:0011514) | 2.08529577 |
| 96 | Diplopia (HP:0000651) | 2.08529577 |
| 97 | Megalencephaly (HP:0001355) | 2.08439907 |
| 98 | Renovascular hypertension (HP:0100817) | 2.08096617 |
| 99 | Ventricular fibrillation (HP:0001663) | 2.07934947 |
| 100 | Bundle branch block (HP:0011710) | 2.05562219 |
| 101 | Hammertoe (HP:0001765) | 2.04821132 |
| 102 | Bowel incontinence (HP:0002607) | 2.04307556 |
| 103 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.04256570 |
| 104 | Lower limb asymmetry (HP:0100559) | 2.02481319 |
| 105 | Epileptiform EEG discharges (HP:0011182) | 2.02197417 |
| 106 | Exercise intolerance (HP:0003546) | 2.01856057 |
| 107 | Narrow nasal bridge (HP:0000446) | 2.01594397 |
| 108 | Obsessive-compulsive behavior (HP:0000722) | 2.01229001 |
| 109 | Lactic acidosis (HP:0003128) | 1.98954083 |
| 110 | EMG: myopathic abnormalities (HP:0003458) | 1.98265497 |
| 111 | Annular pancreas (HP:0001734) | 1.97575929 |
| 112 | Postural instability (HP:0002172) | 1.97351146 |
| 113 | Status epilepticus (HP:0002133) | 1.97070565 |
| 114 | Action tremor (HP:0002345) | 1.96099587 |
| 115 | Drooling (HP:0002307) | 1.94624484 |
| 116 | Fetal akinesia sequence (HP:0001989) | 1.94341790 |
| 117 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.93431795 |
| 118 | Hemiplegia (HP:0002301) | 1.93055803 |
| 119 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.91642906 |
| 120 | Craniofacial dystonia (HP:0012179) | 1.91419339 |
| 121 | Hyperthyroidism (HP:0000836) | 1.87895000 |
| 122 | Lower limb amyotrophy (HP:0007210) | 1.87782775 |
| 123 | Dysmetria (HP:0001310) | 1.86735376 |
| 124 | Spastic tetraplegia (HP:0002510) | 1.86504273 |
| 125 | Absent speech (HP:0001344) | 1.85948206 |
| 126 | Deep palmar crease (HP:0006191) | 1.84866294 |
| 127 | Thickened helices (HP:0000391) | 1.84528578 |
| 128 | Diminished motivation (HP:0000745) | 1.84454707 |
| 129 | Hepatic necrosis (HP:0002605) | 1.84219916 |
| 130 | Torticollis (HP:0000473) | 1.83955143 |
| 131 | Hemiparesis (HP:0001269) | 1.83652929 |
| 132 | Emotional lability (HP:0000712) | 1.83258076 |
| 133 | Ventricular arrhythmia (HP:0004308) | 1.82961663 |
| 134 | Mutism (HP:0002300) | 1.82953626 |
| 135 | Rapidly progressive (HP:0003678) | 1.82249479 |
| 136 | Abnormality of alanine metabolism (HP:0010916) | 1.81970916 |
| 137 | Hyperalaninemia (HP:0003348) | 1.81970916 |
| 138 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.81970916 |
| 139 | Spinal canal stenosis (HP:0003416) | 1.81844697 |
| 140 | Abnormality of the lower motor neuron (HP:0002366) | 1.81334105 |
| 141 | Spastic tetraparesis (HP:0001285) | 1.81229956 |
| 142 | Split foot (HP:0001839) | 1.80932236 |
| 143 | Congenital malformation of the right heart (HP:0011723) | 1.80658234 |
| 144 | Double outlet right ventricle (HP:0001719) | 1.80658234 |
| 145 | Tetraplegia (HP:0002445) | 1.80502483 |
| 146 | Elfin facies (HP:0004428) | 1.80369902 |
| 147 | Abnormal large intestine physiology (HP:0012700) | 1.80346006 |
| 148 | Optic disc pallor (HP:0000543) | 1.79644555 |
| 149 | Bradykinesia (HP:0002067) | 1.79333003 |
| 150 | Excessive salivation (HP:0003781) | 1.79257348 |
| 151 | Poor suck (HP:0002033) | 1.76996132 |
| 152 | Focal dystonia (HP:0004373) | 1.76918484 |
| 153 | Truncus arteriosus (HP:0001660) | 1.73479545 |
| 154 | Attention deficit hyperactivity disorder (HP:0007018) | 1.72621838 |
| 155 | Abnormality of the aortic arch (HP:0012303) | 1.72279092 |
| 156 | Hypoplasia of the corpus callosum (HP:0002079) | 1.70777207 |
| 157 | Overriding aorta (HP:0002623) | 1.70140373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.80074547 |
| 2 | NTRK3 | 3.67301458 |
| 3 | ARAF | 2.56545479 |
| 4 | MAP3K9 | 2.50344210 |
| 5 | MINK1 | 2.43961243 |
| 6 | MAP3K12 | 2.39106212 |
| 7 | CDK12 | 2.16337937 |
| 8 | MAP3K4 | 2.14479304 |
| 9 | MAP3K11 | 2.11021853 |
| 10 | LMTK2 | 2.00838448 |
| 11 | PLK2 | 2.00226102 |
| 12 | MAP2K7 | 1.99956028 |
| 13 | PDK3 | 1.87847632 |
| 14 | PDK4 | 1.87847632 |
| 15 | MAP3K10 | 1.87387346 |
| 16 | NTRK2 | 1.83474457 |
| 17 | PHKG1 | 1.79048258 |
| 18 | PHKG2 | 1.79048258 |
| 19 | MAP2K4 | 1.78918466 |
| 20 | CASK | 1.75294688 |
| 21 | DAPK2 | 1.74109663 |
| 22 | KSR2 | 1.70670809 |
| 23 | KSR1 | 1.60415061 |
| 24 | PINK1 | 1.56046270 |
| 25 | PDK2 | 1.55408809 |
| 26 | LATS2 | 1.54406828 |
| 27 | RIPK1 | 1.50942346 |
| 28 | DAPK1 | 1.50764767 |
| 29 | PAK6 | 1.49089976 |
| 30 | TESK1 | 1.45536439 |
| 31 | BRD4 | 1.27080999 |
| 32 | MARK1 | 1.25733824 |
| 33 | TTN | 1.25228582 |
| 34 | GRK5 | 1.24551896 |
| 35 | NEK1 | 1.22256671 |
| 36 | CDK5 | 1.18490722 |
| 37 | PRKCG | 1.17764463 |
| 38 | PKN2 | 1.16329447 |
| 39 | PTK2B | 1.15736278 |
| 40 | PRPF4B | 1.15284047 |
| 41 | MAP3K13 | 1.14578856 |
| 42 | TAOK2 | 1.12524949 |
| 43 | RIPK4 | 1.12124413 |
| 44 | BMX | 1.11992782 |
| 45 | CAMKK1 | 1.10628933 |
| 46 | MAPK12 | 1.08464470 |
| 47 | TAOK1 | 1.06768197 |
| 48 | PRKD3 | 1.06567990 |
| 49 | CAMK2A | 1.04915452 |
| 50 | SIK2 | 1.04064407 |
| 51 | CAMK1G | 1.03087237 |
| 52 | DYRK1A | 1.02929788 |
| 53 | SIK3 | 1.02783571 |
| 54 | RAF1 | 1.01368411 |
| 55 | MUSK | 1.00910799 |
| 56 | NME1 | 0.99864997 |
| 57 | SCYL2 | 0.98794623 |
| 58 | MAP3K1 | 0.97184121 |
| 59 | MAPK10 | 0.97176063 |
| 60 | NTRK1 | 0.95603443 |
| 61 | SIK1 | 0.95211003 |
| 62 | DAPK3 | 0.93319864 |
| 63 | TRIB3 | 0.90677042 |
| 64 | DDR2 | 0.88765612 |
| 65 | MAP3K6 | 0.88521509 |
| 66 | BRAF | 0.87625660 |
| 67 | SGK494 | 0.86418559 |
| 68 | SGK223 | 0.86418559 |
| 69 | CDK14 | 0.86265358 |
| 70 | MARK2 | 0.85960363 |
| 71 | CDK18 | 0.83210986 |
| 72 | CAMK1D | 0.81120828 |
| 73 | CDK19 | 0.80695339 |
| 74 | CDK15 | 0.76056213 |
| 75 | ICK | 0.75939678 |
| 76 | MAP3K5 | 0.75468800 |
| 77 | CAMKK2 | 0.74765503 |
| 78 | STK38 | 0.74743866 |
| 79 | FES | 0.74551131 |
| 80 | TNIK | 0.74512906 |
| 81 | PRKCE | 0.73854091 |
| 82 | CSNK1G2 | 0.73397565 |
| 83 | WNK1 | 0.72866504 |
| 84 | DYRK1B | 0.72193991 |
| 85 | ILK | 0.72039808 |
| 86 | MAP2K1 | 0.69699613 |
| 87 | RPS6KA2 | 0.69198501 |
| 88 | CAMK4 | 0.68513992 |
| 89 | TNK2 | 0.68481404 |
| 90 | ERBB4 | 0.68360987 |
| 91 | CDK11A | 0.67990192 |
| 92 | NEK6 | 0.64856625 |
| 93 | MYLK | 0.64206236 |
| 94 | CAMK2B | 0.63288508 |
| 95 | MTOR | 0.62791569 |
| 96 | STK11 | 0.61476127 |
| 97 | MAP3K7 | 0.60602357 |
| 98 | DMPK | 0.59978851 |
| 99 | RET | 0.59927720 |
| 100 | PAK3 | 0.59830093 |
| 101 | MAPK8 | 0.58661356 |
| 102 | ALK | 0.58565513 |
| 103 | MOS | 0.57757187 |
| 104 | UHMK1 | 0.56773306 |
| 105 | CAMK1 | 0.56603813 |
| 106 | PRKCZ | 0.56267175 |
| 107 | PRKD2 | 0.56142920 |
| 108 | GSK3B | 0.56068692 |
| 109 | ADRBK1 | 0.55815959 |
| 110 | MAP2K6 | 0.55169965 |
| 111 | TYRO3 | 0.54179548 |
| 112 | RPS6KA3 | 0.53810685 |
| 113 | MAPK13 | 0.53647692 |
| 114 | ROCK2 | 0.53304614 |
| 115 | BRSK1 | 0.51620960 |
| 116 | CAMK2D | 0.51462635 |
| 117 | PKN1 | 0.49625258 |
| 118 | FER | 0.49397505 |
| 119 | CDC42BPA | 0.48338022 |
| 120 | ERN1 | 0.47390948 |
| 121 | CAMK2G | 0.47303540 |
| 122 | MAPK15 | 0.46590547 |
| 123 | PDK1 | 0.45236039 |
| 124 | PRKAA1 | 0.43560327 |
| 125 | MAP4K2 | 0.43523522 |
| 126 | PRKCH | 0.41983165 |
| 127 | PDPK1 | 0.40978984 |
| 128 | CDK2 | 0.40260265 |
| 129 | EEF2K | 0.39830357 |
| 130 | PNCK | 0.38971054 |
| 131 | CDK1 | 0.38330246 |
| 132 | CCNB1 | 0.37714926 |
| 133 | SGK1 | 0.37667835 |
| 134 | ERBB2 | 0.36389945 |
| 135 | ROCK1 | 0.36315055 |
| 136 | SGK3 | 0.35648125 |
| 137 | CSNK1E | 0.35174122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.82842915 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.31002717 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.68436373 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.64754056 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.52121965 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.36115398 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.33516565 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.28741401 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.22270900 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.18411458 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.18026600 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.15874480 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.95241171 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.92591786 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.85471596 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.85419573 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.77193861 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 1.76577821 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.74213664 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.68782637 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.68575568 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.62200518 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.59835214 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50854172 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.50087823 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.49382062 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.43036744 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.40431978 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40415367 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38779577 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.35267231 |
| 32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.28315272 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.25589359 |
| 34 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.22981546 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.22291082 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.18576137 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16795485 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.13312710 |
| 39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10889256 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09736349 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08645951 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.06611586 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00989902 |
| 44 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.97678979 |
| 45 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97486382 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94811286 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.94229761 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.94042789 |
| 49 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.91478180 |
| 50 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.90527112 |
| 51 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90422952 |
| 52 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90151378 |
| 53 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89093094 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.87845492 |
| 55 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.86372849 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85500865 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.85141547 |
| 58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85120665 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.84198969 |
| 60 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83765853 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82216618 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80441307 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79558647 |
| 64 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.78861818 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78500443 |
| 66 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74939066 |
| 67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74210372 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.74201043 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71901628 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71430063 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67488191 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67292098 |
| 73 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66404251 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65135522 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64500739 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63468264 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58970779 |
| 78 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58505411 |
| 79 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.57626507 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57436394 |
| 81 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.56972094 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56446352 |
| 83 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55472841 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54964576 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54347507 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54320232 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53939197 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53725886 |
| 89 | Axon guidance_Homo sapiens_hsa04360 | 0.52869416 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52656055 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52496188 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.51604977 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51480184 |
| 94 | Bile secretion_Homo sapiens_hsa04976 | 0.51018241 |
| 95 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50705613 |
| 96 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49674917 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49116190 |
| 98 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48876102 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48727517 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48414496 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46738842 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46631991 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45506594 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.43051007 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42968951 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42760737 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42180159 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41756958 |
| 109 | Alcoholism_Homo sapiens_hsa05034 | 0.41040554 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40378464 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40371999 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39768402 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37640775 |
| 114 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37043062 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36554684 |
| 116 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36418420 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36303686 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35916482 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35571401 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.35341640 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33175728 |
| 122 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.32119133 |
| 123 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28994981 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28190099 |

